Medindia

X

GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth

Tuesday, January 27, 2009 General News J E 4
Advertisement
GenVault's energy and space efficient technologies ideally suit the needs of the Japanese Biobanking community, and create a new paradigm for eco-friendly, sustainable Biobanking initiatives.



CARLSBAD, Calif., Jan. 26 /PRNewswire/ -- GenVault Corporation today announces the opening of its newly-formed Japanese subsidiary in order to better serve the needs of the expanding Biobanking market and its growing customer base in Japan. GenVault Japan KK will be responsible for the marketing, selling and technical support of the full range of GenVault products and services in Japan.



GenVault is also delighted to announce that Mr. Junya Tominaga has joined the company in the role of Managing Director, GenVault Japan. Mr. Tominaga has over twenty years of senior management experience in the Japanese life science market place, most recently serving as the Managing Director of Illumina, Japan. Prior to this Mr. Tominaga held positions as Managing Director of Molecular Dynamics Japan and Clontech Japan.



"GenVault is very excited to be establishing a direct presence in Japan. We feel our products and technologies are particularly well suited for use in Japan, and bring strong advantages in terms of space and energy savings. We look forward to serving the needs of our Japanese customers," commented Mark J. Sutherland, Sr. Vice-President of Business Development for GenVault Corporation.



GenVault Japan is located in the ARK Mori Building in the Akasaka district of Tokyo and can be contacted at TEL: +81 (03) 4360-8225 and FAX +81 (03) 4360-8201



About GenVault



GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com.



Contact: Bret Dash

Tel : 760 717 3774

bdash@genvault.com



SOURCE GenVault Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Looking For Easy Accommodation-Visit Go-Sierra-Nev...
S
Virgin Mobile USA Launches Limited Edition Pink Fl...